Acro Biomedical Co., Ltd. (ACBM) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Fishers, IN, United States. The current CEO is Yu-Ting Su.
ACBM has IPO date of 2021-01-08, listed on the Other OTC, a market capitalization of $1.56M.
Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. It sells cordycepin and cordyceps powder, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.
